Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma

Robert S. McNeill, Demitra A. Canoutas, Timothy J. Stuhlmiller, Harshil D. Dhruv, David M. Irvin, Ryan E. Bash, Steven P. Angus, Laura E. Herring, Jeremy M. Simon, Kasey R. Skinner, Juanita C. Limas, Xin Chen, Ralf S. Schmid, Marni B. Siegel, Amanda E.D. Van Swearingen, Michael J. Hadler, Erik P. Sulman, Jann N. Sarkaria, Carey K. Anders, Lee M. GravesMichael E. Berens, Gary L. Johnson, C. Ryan Miller

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences